March 6, 2026

PULLBACK IN MEDICAL DEVICE COMPANY BOSTON SCIENTIFIC (BSX) IS AN OPPORTUNITY FOR LONG TERM INVESTORS

By Nigam Arora

Pullback Is Opportunity

Boston Scientific (BSX) has built one of the strongest franchises in the global medical device industry.  Through disciplined innovation and targeted strategic expansion, the company has consistently strengthened its position in fast growing therapeutic categories.  The pullback in BSX is a buying opportunity for the long term investor.

Reason For Pullback

The pullback in BSX is the direct result of the company’s acquisition of Penumbra (PEN).

Markets frequently react negatively when a major acquisition is announced or completed.  The reason is simple: acquisitions are dilutive in the short term.

When a large company buys another company:

  • Financing costs impact earnings

  • Integration expenses temporarily pressure margins

  • Accounting treatment reduces near term earnings per share

The market focuses on these short term effects. … Please click here or the title below to read more.

Read More

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content